HSP90 INHIBITORS POTENTIALLY OVERCOME CHEMORADIOTHERAPY RESISTANCE ASSOCIATED WITH HER2 AND NFfEB OVEREXPRESSION IN MIBC

被引：0
|
作者：
Yoshida, Soichiro
Koga, Fumitaka
Tatokoro, Manabu
Kawakami, Satoru
Fujii, Yasuhisa
Kumagai, Jiro
Neckers, Len
Kihara, Kazunori
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.1091
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1054
引用
收藏
页码：E424 / E424
页数：1
相关论文
共 50 条
  • [1] Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors
    Smith-Jones, PM
    Solit, DB
    Akhurst, T
    Afroze, F
    Rosen, N
    Larson, SM
    NATURE BIOTECHNOLOGY, 2004, 22 (06) : 701 - 706
  • [2] Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors
    Peter M Smith-Jones
    David B Solit
    Timothy Akhurst
    Farzana Afroze
    Neal Rosen
    Steven M Larson
    Nature Biotechnology, 2004, 22 : 701 - 706
  • [3] Development of HER2 targeted HSP90 inhibitors delivery system
    Lim, Kwangsuk
    Hong, Yudong
    Won, Young-Wook
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Insights into designing the dual-targeted HER2/HSP90 inhibitors
    Chen, Chien-Yu
    Chen, Calvin Yu-Chian
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 29 (01): : 21 - 31
  • [5] HER2 and HSP90 overexpression in respect to KRAS gene status in colorectal cancer
    Bar, J.
    Lis-Nawara, A.
    Lebioda, A.
    Jonkisz, A.
    Grelewski, P.
    Gajdzis, P.
    Dobosz, T.
    Jelen, M.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 315 - 315
  • [6] Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption
    Shao, Yongfeng
    Wang, Bingchan
    Shi, Dorothy
    Miao, Suyu
    Manivel, Panneerselvam
    Krishna, Ramadas
    Chen, Yiding
    Shi, Y. Eric
    MOLECULAR ONCOLOGY, 2014, 8 (08) : 1521 - 1531
  • [7] Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
    Weigert, Oliver
    Lane, Andrew A.
    Bird, Liat
    Kopp, Nadja
    Chapuy, Bjoern
    van Bodegom, Diederik
    Toms, Angela V.
    Marubayashi, Sachie
    Christie, Amanda L.
    McKeown, Michael
    Paranal, Ronald M.
    Bradner, James E.
    Yoda, Akinori
    Gaul, Christoph
    Vangrevelinghe, Eric
    Romanet, Vincent
    Murakami, Masato
    Tiedt, Ralph
    Ebel, Nicolas
    Evrot, Emeline
    De Pover, Alain
    Regnier, Catherine H.
    Erdmann, Dirk
    Hofmann, Francesco
    Eck, Michael J.
    Sallan, Stephen E.
    Levine, Ross L.
    Kung, Andrew L.
    Baffert, Fabienne
    Radimerski, Thomas
    Weinstock, David M.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (02): : 259 - 273
  • [8] Genetic Resistance to JAK2 Enzymatic Inhibitors Is Overcome by HSP90 Inhibition
    Weigert, Oliver
    Lane, Andrew A.
    Bird, Liat
    Kopp, Nadja
    Toms, Angela V.
    Gaul, Christoph
    Vangrevelinghe, Eric
    De Pover, Alain
    Regnier, Catherine H.
    Erdmann, Dirk
    Hofmann, Francesco
    Eck, Michael
    Kung, Andrew L.
    Radimerski, Thomas
    Weinstock, David M.
    BLOOD, 2011, 118 (21) : 30 - 30
  • [9] The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition
    Mishra, Sanket J.
    Liu, Weiya
    Beebe, Kristin
    Banerjee, Monimoy
    Kent, Caitlin N.
    Munthali, Vitumbiko
    Koren, John, III
    Taylor, John A., III
    Neckers, Leonard M.
    Holzbeierlein, Jeffrey
    Blagg, Brian S. J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (03) : 1545 - 1557
  • [10] Development and evaluation of Hsp90 β-selective inhibitors to overcome the safety challenges associated with pan-Hsp90 inhibitors
    Mishra, Sanket
    Reynolds, Tyelor
    Blagg, Brian
    CANCER RESEARCH, 2024, 84 (06)
12345